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INTRODUCTION:
1-3
 
The goal of any drug delivery system is to provide a 
therapeutic amount of drug to the proper site in the body to 
promptly achieve and then maintain the desired drug 
concentration. This idealized objective points to the two 
aspects most important to drug delivery, namely, spatial 
placement and temporal delivery of a drug. Spatial 
placement relates to targeting of a drug to a specific organ 
or tissue, while the temporal delivery refers to controlling 
the rate of drug delivery to target tissue. An appropriately 
designed sustained-release drug delivery system can be a 
major advance towards solving these two problems. 
Man has always been plagued with ailments and diseases 
of both the body and the mind. However dedicated 
research from scientists all over the world has made it 
possible to treat, prevent and eradicate many of these 
diseases that plague man. The field of pharmaceutical 
science has been developing steadily over the years, and 
has today become invaluable in helping to keep us healthy 
and prevent disease. An avenue of research that has 
progressed a great deal in the past few decades is the 
treatment of diseases via biomolecules such as drugs, 
proteins etc. Initially these could only be administered in 
limited manner, due to limitations of drug delivery through 
harmful environments in the body. Thus limited mobility 
reduced the effectiveness of administered drugs. Progress 
came with the development of biomaterial carriers which 
could be encapsulated, or immobilized with drugs, 
allowing the drug to safely reach the required site without 
harm. These carriers allowed for the release of drug in sites 
which were previously inaccessible.  
These are a class of materials known as Hydrogels. These 
three dimensional polymer matrices are capable of 
imbibing large amounts of water, and biological fluids. 
This property of hydrogels is the reason behind its varied 
applications ranging from food additives to 
pharmaceuticals and clinical applications. Synthetic 
hydrogels prepared from a varied range of monomers have 
found many applications especially in tissue-engineering 
scaffolds, as carriers for implantable devices, and drug 
delivery devices. Out of all these applications, at the 
forefront of this research are hydrogel based drug delivery 
devices. Synthetic hydrogels provide an effective and 
controlled way in which to administer protein and peptide 
based drugs for treatment of a number of diseases. 
Stimuli sensitive hydrogels have enormous potential in 
various applications. Some environmental variables, such 
as low pH and elevated temperature, are found in the body. 
For this reason either pH sensitive or temperature sensitive 
hydrogels can be used for site specific controlled drug 
delivery. Hydrogels that are responsive to specific 
molecules, such as glucose or antigens, can be used as 
biosensors as well as drug delivery system. 
Environmentally sensitive hydrogels for drug delivery 
application also require biocompatibility.  
PROPERTIES OF HYDROGELS:
4 
Hydrogels are water swollen polymer matrices, with a 
tendency to imbibe water when placed in aqueous 
environment. This ability to swell, under biological 
conditions, makes it an ideal material for use in drug 
delivery and immobilization of proteins, peptides, and 
other biological compounds. Due to their high water 
content, these gels resemble natural living tissue more than 
any other type of synthetic biomaterial. These networks, 
have a three dimensional structure, crosslinked together 
either physically (entanglements, crystallites), or 
chemically (tie-points, junctions). This insoluble 
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crosslinked structure allows immobilization of active 
agents, biomolecules effectively, and allows for its release 
in well-defined specific manner. Thus the hydrogels 
biocompatibility and crosslinked structure are responsible 
for its varied applications. 
1. Mechanical properties: 
For non biodegradable applications, it is essential that the 
carrier gel matrix maintain physical and mechanical 
integrity. Mechanical stability of the gel is, therefore, an 
important consideration when designing a therapeutic 
system. For example, drugs and other biomolecules must 
be protected from the harmful environments in the body 
such as, extreme pH environment before it is released at the 
required site. To this end, the carrier gel must be able to 
maintain its physical integrity and mechanical strength in 
order to prove an effective biomaterial. The strength of the 
material can be increased by incorporating crosslinking 
agents, co-monomers, and increasing degree of 
crosslinking. There is however an optimum degree of 
crosslinking, as a higher degree of crosslinking also leads 
to brittleness and less elasticity. Elasticity of the gel is 
important to give flexibility to the crosslinked chains, to 
facilitate movement of incorporated bioactive agent. Thus 
a compromise between mechanical strength and flexibility 
is necessary for appropriate use of these materials. 
2. Biocompatible properties: 
It is important for synthetic materials, such as hydrogels, to 
be biocompatible and nontoxic in order for it to be a useful 
biomedical polymer. Most polymers used for biomedical 
application must pass a cytotoxicity and in-vivo toxicity 
tests. Most toxicity problems associated with hydrogels 
arise due to unreacted monomers, oligomers and initiators 
that leach out during application. Thus an assessment of 
the potential toxicity of all materials used for fabrication of 
gel is an integral part of determining suitability of the gel 
for biological applications. To lower chances of toxic 
effects, the use of initiators is being eliminated, with the 
advent of gamma irradiation as polymerization technique. 
Steps are also taken to eliminate contaminants from 
hydrogels, by repeated washing and treatment. Also, 
kinetics of polymerization has been studied, so as to 
achieve higher conversion rates, and avoid unreacted 
monomers and side products. 
CLASSIFICATION OF HYDROGELS:
 5
 
Hydrogels can be classified as neutral or ionic, based on 
the nature of side groups. In neutral hydrogels, the driving 
force for swelling is due to the water-polymer 
thermodynamic mixing contribution to the overall free 
energy, along with elastic polymer contribution. The 
swelling of ionic hydrogels is also affected by the ionic 
interactions between charged polymers and free ions. Ionic 
hydrogels containing ionic groups, such as carboxylic acid, 
imbibe larger amount of water, because of its increased 
hydrophilicity. Examples of such gels are poly (acrylic 
acid), and polyamines. Hydrogels are also classified as 
homopolymers or copolymers, based on the method of 
preparation. Hydrogels can be classified based on the 
physical structure of the network as amorphous, 
semicrystalline, hydrogen bonded structures, 
supermolecular structures and hydrocolloidal aggregates. 
An important class of hydrogels are the stimuli responsive 
gels. These gels show swelling behaviour dependent on 
their physical environment. These gels can swell, or 
deswell in response to changes in pH, temperature, ionic 
strength, and electromagnetic radiation. These properties 
allow for usage in a number of applications, such as 
separation membranes, biosensors, artificial muscles, and 
drug delivery devices. 
Stimuli responsive gels: 
6
 
Stimuli sensitive hydrogels have enormous potential in 
various applications. Some environmental variables, such 
as low pH and elevated temperature, are found in the body. 
For this reason either pH sensitive or temperature sensitive 
hydrogels can be used for site specific controlled drug 
delivery. Hydrogels that are responsive to specific 
molecules, such as glucose or antigens, can be used as 
biosensors as well as drug delivery system (Figure 1).  
 
 
Figure 1: Stimuli responsive swelling of hydrogels 
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1. Temperature sensitive hydrogels:  
1.1 Polymer structure: 
Many polymers exhibit a temperature responsive phase 
transition property. The common characteristic of 
temperature sensitive polymers is the presence of 
hydrophobic groups, such as methyl, ethyl and propyl 
groups. Of the many temperature sensitive polymers, poly 
(N-iso-propylacrylamide) (PNIPAAm) is probably the 
most extensively used. Poly (N, N-diethylacrylamide) 
(PDEAAm) is also widely used because of its lower 
critical solution temperature (LCST) in the range of 25-
32˚C, close to the body temperature. 
1.2 Properties of temperature sensitive hydrogels: 
Most polymers increase their water solubility as the 
temperature increases. Polymers with LCST, however, 
decrease their water solubility as the temperature increases 
above the LCST. This type of swelling behaviour is known 
as inverse (or negative) temperature dependence. The 
inverse temperature dependent hydrogels are made of 
polymer chains that either posses moderately hydrophobic 
groups (if too hydrophobic, polymer chains would not 
dissolve in water at all) or contain mixture of hydrophilic 
and hydrophobic segments.  
At lower temperatures, hydrogen bonding between 
hydrophilic segments of the polymer chain and water 
molecules are dominates, leading to enhanced dissolution 
in water. As the temperature increases, however, 
hydrophobic interactions among hydrophobic segments 
become strengthened, while hydrogen bonding becomes 
weaker. The net result is shrinking of the hydrogels due to 
inter-polymer chain association through hydrophobic 
interactions. The LCST can be changed by adjusting the 
ratio of hydrophilic and hydrophobic segment of the 
polymer.  If the polymer chains in hydrogels are not co-
valently cross linked, temperature sensitive hydrogels may 
undergo sol-gel phase transitions, instead of swelling-
shrinking transitions. Polymers that show this type of 
behaviour are block copolymers of PEO and PPO. 
Temperature sensitive hydrogels can also be made using 
temperature-sensitive crosslinking agents. 
2 pH sensitive hydrogels: 
2.1 Polymer structures: 
All the pH-sensitive polymers contain pendant acidic (e.g. 
carboxylic and sulphonic acid) or basic (e.g. ammonium) 
groups that either accept or release protons in response to 
change in environmental pH. The polymers with a large 
number of ionizable groups are known as polyelectrolytes. 
Poly acrylic acid (PAA) becomes ionized at high pH, while 
poly (N, N’-diethylaminoethyl methacrylate) (PDEAEM) 
becomes ionized at low pH. Cationic polyelectrolyte, such 
as PDEAEM, dissolve more or swell more if crosslinked at 
low pH due to ionization. On the other hand, polyanions, 
such as PAA, dissolve more at high pH. 
2.2 Properties of pH-sensitive hydrogels: 
Hydrogels made of crosslinked polyelectrolyte’s display 
big differences in swelling properties depending on the pH 
of the environment. The pendant acidic or basic groups on 
polyelectrolyte undergo ionization just like acidic or basic 
groups of monoacids or monobases. The presence of 
ionizable groups on polymer chains result in swelling of 
the hydrogels much beyond that can be achievable by 
nonelectrolyte polymer hydrogels. Swelling of 
polyelectrolyte hydrogels is mainly due to the electrostatic 
repulsion among charges present on the polymer chain.  
Different co-monomers provide different hydrophobicity 
to the polymer chain, leading to different pH-sensitive 
behaviour. Hydrogels made of poly (methacrylic acid) 
(PMA) grafted with poly (ethylene glycol) (PEG) have 
unique pH-sensitive properties. At low pH, the acidic 
protons of the carboxyl groups of PMA interact with the 
ether oxygen of PEG through hydrogen bonding, and such 
complexation results in shrinkage of hydrogels. As the 
carboxyl groups of PMA become ionized at high pH, the 
resulting decomplexation leads to swelling of hydrogels 
(Figure 2).  
 
Figure 2: Environmental sensitive swelling-controlled 
release system 
3 Glucose sensitive hydrogels: 
One of the most challenging problems in controlled drug 
delivery area is the development of self-regulated 
(modulated) insulin delivery system. Delivery of insulin is 
different from delivery of other drugs, since insulin has to 
be delivered in an exact amount at the exact time of need. 
Thus, self-regulated insulin delivery systems require the 
glucose sensing ability and an automatic shut-off 
mechanism. Many hydrogel systems have been developed 
for modulating insulin delivery, and all of them have a 
glucose sensor built into the system.  
Glucose oxidase is probably the most widely used enzyme 
in glucose sensing. It oxidizes glucose to gluconic acid, 
resulting in a pH change of the environment. This makes it 
possible to use different types of pH-sensitive hydrogels 
for modulated insulin delivery. 
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4 Electric signal-sensitive hydrogels: 
Electric current can also be used as an environmental 
signal to induce responses of hydrogels. Hydrogels 
sensitive to electric current are usually made of 
polyelectrolytes, as are pH sensitive hydrogels. Sometimes 
the hydrogels show swelling on one side and deswelling on 
other side, resulting in bending of the hydrogels. Partially 
hydrolyzed polyacrylamide hydrogels which are in contact 
with both the anode and cathode electrodes undergo 
volume collapse by an infinitesimal change in electric 
potential across the gel. 
5 Light-sensitive hydrogels: 
Light sensitive hydrogels have potential application in 
developing optical switches, display units, and ophthalmic 
drug delivery devices. Since the light stimulus can be 
impose instantly and delivered in specific amounts with 
high accuracy, light sensitive hydrogels may posses special 
advantage over others. For example, sensitivity of 
temperature controlled hydrogels rate limited by thermal 
diffusion, while pH sensitive hydrogels can be limited by 
hydrogen ion diffusion. Light sensitive hydrogels can be 
separated in to UV-sensitive and visible light sensitive 
hydrogels. 
The UV-sensitive hydrogels were synthesized by 
introducing a leuco derivative molecule, bis (4-di-
methylamino) phenylmethyl leucocynide, in to the 
polymer network. Visible light sensitive hydrogels were 
prepared by introducing a light sensitive chromophore (e.g. 
tri sodium salt of copper chlorophyllin) to poly (N-iso-
propylacrylamide). 
6 Pressure sensitive hydrogels: 
The concept that hydrogels may undergo pressure induced 
volume phase transition came from thermodynamic 
calculation based on uncharged hydrogel theory. 
According to the theory, hydrogels which are collapsed at 
low pressure would expand at higher pressure. 
Experiments with poly (N-iso-propylacrylamide) 
hydrogels confirmed this prediction. The degree of 
swelling of poly (N-iso-propylacrylamide) hydrogels 
increased under hydrostatic pressure when the temperature 
is close to its LCST. 
7 Specific ion sensitive hydrogels:  
Little or no effect of salt concentration on swelling 
behaviour is expected for neutral hydrogels. A nonionic 
poly (N-iso-propylacrylamide) hydrogel, however, showed 
a sharp volume phase transition at a critical concentration 
of sodium chloride in aqueous solution. Below the LCST, 
the water content of the hydrogel is a strong function of the 
sodium chloride concentration.  
The gel collapse sharply at a critical sodium chloride 
concentration, this concentration is also found to be 
temperature dependent. Increasing temperatures leads to a 
corresponding decrease in the critical concentration of 
sodium chloride. The LCST of the hydrogel appeared to be 
lowered by increasing the chloride concentration. This 
unique phase transition behaviour could be applicable to 
making chloride ion sensitive biosensors. 
8 Specific antigen-responsive hydrogels: 
For some biomedical applications, it is highly desirable 
and useful to develop a material or devices, which can 
response to specific proteins. Sol-gel phase reversible 
hydrogels were prepared based on antigen-antibody 
interactions. The concept is same as that used in glucose 
sensitive phase reversible hydrogels. A semi-
interpenetrating network hydrogels was prepared by 
grafting an antigen and a corresponding antibody to 
different polymer networks. The gel is formed by 
crosslinking interactions that occur upon antigen-antibody 
binding. 
9 Thrombin-induced infection responsive hydrogels: 
For release of antibiotics at the site and time of infection, 
PVA hydrogels loaded with grafted gentamycin were 
made. Gentamycin was chemically attached to the polymer 
backbone through peptide linkers that can enzymatically 
degraded by thrombin. This type of approach can be 
applied to occlusive wound dressing and infection prone 
catheters, drainage bags and prostheses. 
MONOMERS USED FOR FABRICATION OF 
HYDROGELS: 
7 
The monomers used for fabrication of these biocompatible 
hydrogels have expanded from a handful of choices, to 
several novel materials with tailor-made properties suited 
to particular applications. The first synthesis of hydrogel 
was done by Wichterle and Lin using PHEMA (poly 
(hydroxyethyl methacrylate)) as the monomer. Depending 
upon the application, hydrogel monomers are chosen 
according to their properties, ease of delivery or 
encapsulations, as well as cost and availability. One of the 
most traditional monomers used for drug delivery of 
proteins is biodegradable PLGA (polymers of lactic and 
glycolic acid). 
Table 1: Monomers used for biomaterial synthesis.8 
Monomer 
Abbreviation 
Monomer 
           HEMA Hydroxyethyl methacrylate 
           HEEMA Hydroxyethoxyethyl methacrylate 
           HDEEMA Hydroxydiethoxyethyl methacrylate 
           MEMA Methoxyethyl methacrylate 
           MEEMA Methoxyethoxyethyl methacrylate 
           MDEEMA Methoxydiethoxyethyl methacrylate 
           EGDMA Ethylene glycol dimethacrylate 
           NVP N-vinyl-2-pyrrolidone 
           NIPAAm N-isopropyl AAm 
           Vac Vinyl acetate 
           AAc Acrylic acid 
           MAA Methacrylic acid 
           HPMA N-(2-hydroxypropyl) methacrylamide 
           EG Ethylene glycol 
           PEGA PEG acrylate 
           PEGMA PEG methacrylate 
           PEGDA PEG diacrylate 
           PEGDMA PEG dimethacrylate 
 
However these hydrophobic materials have a tendency to 
denature protein as well as cause inflammation due to 
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degradation. These problems were overcome when 
researchers turned towards hydrophilic monomers. 
Monomers such as acrylic acid, polyethylene glycol, and 
methacrylic acid are all materials used in therapeutic 
applications. PNIPAAm poly (Nisopropylacrylamide), 
PVA (polyvinyl alcohol), is all synthesized by new 
preparation techniques, for distinct applications. Table 
provides a list of popular monomers used for biomaterial 
synthesis (Table 1).  
APPLICATIONS OF HYDROGELS:
 9 
Water- swollen crosslinked hydrogels have varied 
applications in fields such as food additives, 
pharmaceutical as well as biomedicine. The pioneering 
work on crosslinked HEMA hydrogels was done by 
Wichterle and Lim in 1954. From their research, and 
discovery of the hydrophilic and biocompatible properties 
of hydrogels, there emerged a new class of hydrogel 
technologies based on biomaterial application. Lim and 
Sun in 1980 demonstrated the successful use of calcium 
alginate microcapsules for cell encapsulation. Later natural 
polymers such as collagen, and shark cartilage were 
incorporated into hydrogels as wound dressings. Natural 
and synthetic polymers are used for encapsulation of cells, 
as well as encapsulation of islets in a semi permeable 
membrane. Hydrogels have been used to prevent adhesions 
and prevent thrombosis after surgery, and as cell adhesion 
resistant surfaces. Microfabricated hydrogel arrays are also 
used for biosensing. 
 Hydrogels now play an important role in tissue 
engineering scaffolds, biosensor and BioMEMS devices 
and drug carriers. Among these applications, hydrogel-
based drug delivery devices have become a major area of 
study, and several commercially available products are 
already in the market. Proteins, peptides, DNA based drugs 
can all be delivered via hydrogel carrier devices. 
1 Hydrogels in Drug Delivery: 
10
 
Localized drug delivery can be achieved by introducing 
the drug directly at the target site. The major class of 
biomaterials considered as implantable drug delivery 
systems are hydrogels. These hydrophilic networks are 
capable of absorbing great amounts of water while 
maintaining structural integrity. Their structural similarity 
to the extracellular matrix makes it biocompatible. These 
synthetic polymers have generated wide interests and are 
now at the forefront of drug delivery research. 
In order to incorporate a preformed gel into the body, an 
opening must be created, with at least the same dimension 
as that of the gel. This leads to potential risk and 
discomfort to the patient. Thus focus has shifted to 
developing injectable materials with ability to form three 
dimensional matrices under physiological matrices. This 
in-situ formation can be achieved through specific 
chemical crosslinking reactions. Gel structuring is 
triggered by environmental stimuli (pH, temperature, 
solvent exchange etc). Synthetic hydrogels, with their 
ability to imbibe water, flexibility, and biocompatibility, 
are ideal carriers for the development for novel 
pharmaceutical formulations and for the delivery of drugs, 
proteins, and as targeting agents for drug delivery. The 
network structure and the nature of components play a key 
role in the diffusional behaviour, molecular mesh size 
changes, and stability of the incorporated bioactive agent. 
The use of hydrogels allows not only delivery of drugs, but 
also controlled release, in the manner required by the 
pharmaceutical scientists. For example, drugs can be 
delivered only when needed, may be directed to specific 
site, and can be delivered at specific rates required by the 
body.  
2 Properties useful in drug delivery: 
11
 
Hydrogels possess several properties that make them an 
ideal material for drug delivery. First, hydrogels can be 
tailored to respond to a number of stimuli. This enables 
sustained drug delivery corresponding to external stimuli 
such as pH or temperature. These pH sensitive gels are 
useful in oral drug delivery as they can protect proteins in 
the digestive track. pH responsiveness is also useful for 
lysosomal escape during gene delivery. Second, Hydrogels 
can also be synthesized to exhibit bioadhesiveness to 
facilitate drug targeting, especially through mucus 
membranes, for non-invasive drug administration. Finally, 
Hydrogels also have a “stealth” characteristic in-vivo 
circulation time of delivery device by evading the host 
immune response and decreasing phagocytic activity. 
3 Applications of hydrogels in drug delivery: 
12
 
Advances in recombinant protein technology have 
identified several protein and peptide therapeutics for 
disease treatment. However, the problem which plagued 
researchers was how to effectively deliver these 
biomolecules. Due to their large molecular weight, and 
three dimensional structure, the most commonly used route 
for drug administration is by intravenous or subcutaneous 
injection. Unfortunately proteins and peptides are prone to 
proteolytic degradation, thus they experience short plasma 
circulation times and rapid renal clearance, leading to 
multiple daily injections or increased dosage in order to 
maintain the required drug therapeutic levels . Multiple 
injections are difficult for the patient, while high doses 
might be toxic, and induce serious immune response. 
Hydrophobic polymeric controlled release formulations, 
such as PLGA, offer a sustained release mechanism in 
which drug release rates can manipulated by changing 
polymer molecular weight and composition. These 
polymers however induce adverse effects to the 
encapsulated proteins or peptides during network 
preparation and delivery, as well as trigger the immune 
response. Hydrophilic hydrogels, on the other hand, 
provide relatively mild network fabrication technique and 
drug encapsulation conditions, making them the ideal 
material for use in drug delivery. Thus hydrogels are 
primarily used for encapsulation of bioactive materials and 
their subsequent controlled release. 
If designed properly, hydrogels can be used in a variety of 
applications such as sustained, targeted, or stealth 
biomolecules delivery. Hydrogel based delivery devices 
can be used for oral, ocular, epidermal and subcutaneous 
application. The Figure 3 below indicates various sites that 
are available for the application of hydrogels for drug 
delivery. These applications are discussed in detail below. 
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Table 2: Biomedical applications of synthetic hydrogels 
Coatings Homogeneous Materials Devices 
 Sutures 
 Catheters 
 Blood detoxicants 
 Sensors 
 Vascular grafts 
 Electrophoresis cells 
 Cell structure substrates 
 Electrophoresis gels 
 Contact lenses 
 Artificial corneas 
 Oestrous –Induces 
 Soft tissue substitutes 
 Burn dressings 
 Dentures 
 Ear drum plugs 
 Haemodialysis 
 membranes 
 Vitreous-humour 
replacements 
 
 Enzyme  therapeutic 
 systems 
 Artificial organs 
 Sustained drug delivery systems 
 
 
3.1 Drug delivery in the GI tract: 
The ease of administration of drugs, and the large surface 
area for absorption makes the GI tract most popular route 
for drug delivery. It is however, also a very complex route, 
so that versatile approaches are needed to deliver drugs for 
effective therapy. Hydrogel-based devices can be designed 
to deliver drugs locally to specific sites in the GI tract. 
For example, Patel and Amiji,13 proposed stomach–
specific antibiotic drug delivery systems for the treatment 
of Helicobacter pylori infection in peptic ulcer disease. 
They developed cationic hydrogels with pH sensitive 
swelling and drug release properties for antibiotic delivery 
in the acidic environment of the stomach. There are still 
many drawbacks for peroral delivery of peptides and 
proteins to GI tract, like protein inactivation by digestive 
enzymes in the GI tract and poor epithelial permeability of 
the drugs. However certain hydrogels may overcome some 
of these problems by appropriate molecular design or 
formulation. For example Akiyama3 reported novel peroral 
dosage forms of hydrogel formulations with protease 
inhibitory activities. 
Recently oral insulin delivery using pH responsive 
complexation hydrogels was reported.14 The hydrogels 
used were crosslinked copolymers of PMMA with graft 
chains of polyethylene glycol. These hydrogels protect the 
insulin in the harsh, acidic environment of the stomach 
before releasing the drug in the small intestine. The 
colonic region has also been considered as a possible 
absorption site for orally administered proteins and 
peptides, mostly due to a lower proteolytic activity in 
comparison to that in the small intestine. Several hydrogels 
are currently being investigated as potential devices for 
colon-specific drug delivery. These include chemically or 
physically crosslinked polysaccharides such as dextran, 
guar gum and insulin. They are designed to be highly 
swollen or degraded in the presence of colonic enzymes or 
micro flora, providing colon-specificity in drug delivery. 
. 
Figure 3: Tissue locations applicable for hydrogel based 
drug delivery systems 
3.2 Rectal delivery: 
This route has been used to deliver many types of drugs for 
treatment of diseases associated with the rectum, such as 
haemorrhoids. This route is an ideal way to administer 
drugs suffering heavy first-pass metabolism. There are 
however, some drawbacks associated with rectal delivery. 
For example, due to discomfort arising from given dosage 
forms, there is substantial variability in patient’s 
acceptance of treatment. Also, if drugs diffusing out of the 
suppositories are delivered in an uncontrolled manner, they 
are unable to be retained at a specific position in the 
rectum, and tend to migrate upwards to the colon. This 
leads to variation of availability of drugs, especially those 
that undergo extensive first-pass elimination.  Hydrogels 
offer a way in which to overcome these limitations, 
provided that the hydrogels show bioadhesive properties. It 
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was reported that increased bioavailability of propranolol 
subject to extensive first-pass metabolism was observed by 
adding certain mucoadhesive polymeric compounds to 
poloxamer based thermally gelling suppositories.19 The 
polymeric compounds tested were polycarbophil and 
sodium alginate.  
3.3 Ocular delivery: 
Drug delivery to the eye is difficult due to its protective 
mechanisms, such as effective tear drainage, blinking, and 
low permeability of the cornea. Thus, eye drops containing 
drug solution tends to be eliminated rapidly from the eye 
and the drugs show limited absorption, leading to poor 
ophthalmic bioavailability. Due to the short retention time, 
a frequent dosing regimen is necessary for required 
therapeutic efficacy. These challenges have motivated 
researchers to develop drug delivery systems that provide 
prolonged residence time. The earlier dosage forms, such 
as suspension and ointments could be retained in the eye, 
but sometimes gave patients an unpleasant feeling because 
of the nature of solids and semisolids. Hydrogels, because 
of their elastic properties can represent an ocular drainage-
resistant device. In-situ forming hydrogels are attractive as 
an ocular drug delivery system because of their facility in 
dosing as a liquid, and long term retention property as a 
gel after dosing. Cohen et al.7 developed an in-situ gelling 
system of alginate with high gluconic acid contents for the 
ophthalmic delivery of pilocarpine. This system extended 
the duration of the pilocarpine to 10 hr, compared to 3 hr 
when pilocarpine nitrate was dosed as a solution.  
3.4 Transdermal delivery: 
Drug delivery to the skin has been generally used to treat 
skin diseases or for disinfection of the skin. In recent 
years, however a transdermal route for the delivery of 
drugs has been investigated. Swollen hydrogels can be 
delivered for long duration and can be easily removed. 
These hydrogels can also bypass hepatic first-class 
metabolism, and are more comfortable for the patient. 
Hydrogel based delivery devices have been proposed by 
Sun et al.15 such as composite membranes of crosslinked 
PHEMA with a woven polyester support. Also hydrogels 
have been reported which have been obtained by the 
copolymerization of bovine serum albumin (BSA) and 
PEG.16 These hydrogels can be used as controlled release 
devices in the field of wound dressing.  
Current research in this field is now focused on 
electrically-assisted delivery using iontophoresis and 
electroporation. Hydrogel-based formulations are being 
looked at for transdermal iontophoresis to obtain enhanced 
permeation of products in question such as, hormones and 
nicotine.13 
3.5 Subcutaneous delivery: 
Among the varied possible pharmaceutical applications of 
hydrogels, the most substantial application is probably in 
implantable therapeutics. Implantable devices that are 
subcutaneously inserted tend to illicit immune response of 
the body, leading to inflammation, carcinogenicity and 
immunogenicity. Thus biocompatibility becomes a major 
issue, and all implantable materials must be compatible 
with the body. Hydrogels are an ideal candidate for 
implantable materials. They have high water content, 
environment similar to biological tissue, making them 
relatively biocompatible. They also have other properties 
which make them a viable choice:17  
 Minimal mechanical irritation upon in-vivo 
implantation due to their soft, elastic properties.  
 Prevention of protein absorption and cell adhesion 
arising from the low interfacial tension between water 
and hydrogels. 
 Broad acceptability for individual drugs with different 
hydrophilicities and molecular sizes. 
 Manipulate crosslinking density and swelling for 
release of incorporated drug in specific manner. Thus 
hydrogels are an ideal material to be used for delivery 
of proteins and peptides. 
Hydrogel formulations for subcutaneous delivery of 
anticancer drugs have been proposed. For example, 
crosslinked PHEMA was applied to cyratabine (Ara-C). 
Current studies on implantable hydrogels are leading 
towards the development of biodegradable systems, which 
don’t require surgical removal once the drug has been 
administered.  
Biodegradable PEG hydrogels are now at the forefront of 
this research and several novel systems have been 
developed. One type is synthesized via a polycondensation 
reaction between functional PEG acids and branched PEG 
polyols. Another type is PEG based hydrogels having 
functional groups in which the protein drugs can be 
covalently attached to the gel network via ester linkages. 
In this case, the release of the immobilized proteins would 
be controlled by the hydrolysis of ester linkage between 
the gel and protein, followed by diffusion of protein, and 
degradation of gel. 
HYDROGELS AS BIOMATERIALS:
18 
 
The field of biomedical research has advanced rapidly in 
the past several years, mainly as a result of attempts to 
replace body tissues with natural or synthetic biomaterials. 
Success in the application of biomaterials is strictly 
confined to their biocompatibility. The term 
biocompatibility is referred to as the appropriate biological 
performance, both local and systematic of a given 
biomaterial in a specific application. An appropriate 
response of the biomaterial for its particular application 
would be referred to as an inert or positive interaction with 
the host. One promising class of biomaterials in this field 
of research is that of polymeric hydrogels (Table 2). 
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